The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of the prognostic role of FGFR4 Gly388Arg polymorphism with treatment outcomes after chemoradiotherapy in esophageal cancer.
Sanghee Cho
No relevant relationships to disclose
Min-Ho Shin
No relevant relationships to disclose
Jun-Eul Hwang
No relevant relationships to disclose
Hyung-jung Shim
No relevant relationships to disclose
Min-Jee Kim
No relevant relationships to disclose
Ik-Joo Chung
No relevant relationships to disclose